DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20202283

Histopathological spectrum of disorders of sexual development: a case series of seven cases

Saroj Ashok Bolde, Arva Ali Pirosha, Sushma N. Ramraje, Shubhangi V. Agale

Abstract


Disorders of sexual development (DSD) refer to cases in which there is a discordance among at least two of the following; genetic sex, gonadal sex, genital tract sex and phenotypic sex. DSDs are quite rare with reported incidence varying from 1 in 4,500 to 1 in 5,500. Ovotesticular disorder is amongst the rarest variety of DSD comprising only to 3-10% of all cases of DSD with only 500 cases reported till now worldwide. Frequency of MRKH syndrome is 1 in 4,500 cases and is the cause of amenorrhoea in 15% of cases of primary amenorrhoea. Authors present a case series of seven cases of DSDs with three cases diagnosed as androgen insensitivity syndrome, two cases of true ovotesticular DSD (true hermaphrodite), one case each of mixed gonadal dysgenesis and Mayer-Rokitansky-Kuster Hauser (MRKH) syndrome. Authors received the histopathology specimen of these cases in this department which was extensively sampled to study the gonads and the other derivatives of Mullerian and Wolffian duct and to rule out presence of any malignancy.


Keywords


Androgen insensitivity, Disorder of sexual development, Hermaphrodite, Mixed gonadal dysgenesis, Ovotestis

Full Text:

PDF

References


García-Acero M, Moreno O, Suárez F, Rojas A. Disorders of Sexual Development: Current Status and Progress in the Diagnostic Approach. Curr Urol. 2020;13(4):169-78.

Lee PA, Houk CP, Ahmed SF, Hughes IA. International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics. 2006;118(2):e488-e500.

Sax L. How common is intersex? A response to AnneFausto Sterling. J Sex Res. 2002;39:174-8.

Thomas M. Ulbright and Daniel M. Berney, Testicular and paratesticular tumours, non-neoplastic diseases of the testis. In: Sternberg’s, Stacey E, Mills, eds. Diagnostic Surgical Pathology. 5th Edition. Philadelphia, Lippincott Williams and Wilkins; 2010: 1935-1940.

Matsui F, Shimada K, Matsumoto F, Itesako T, Nara K, Ida S, Nakayama M. Long‐term outcome of ovotesticular disorder of sex development: A single center experience. Int J Urol. 2011 Mar;18(3):231-6.

Ovotesticular Disorder of Sexual Development NORD (National Organisation for Rare Disorders). Available at: https://rarediseases.org/rare-diseases/ovotesticular-disorder-of-sex-development/.

Pang S, Wallace MA, Hofman L, Thuline HC, Dorche C, Lyon IC, et al. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics. 1988 Jun 1;81(6):866-74.

Thyen U, Lanz K, Holterhus PM, Hiort O. Epidemiology and initial management of ambiguous genitalia at birth in Germany. Horm Res. 2006;66(4):195-203.

Watanabe K, Kobayashi Y, Banno K, Matoba Y, Kunitomi H, Nakamura K, et al. Recent advances in the molecular mechanisms of Mayer‑Rokitansky‑Küster‑Hauser syndrome (Review) Corrigendum in/10.3892/br. 2017.1018. Biomedi Rep. 2017 Aug 1;7(2):123-7.

Cools M, Looijenga L. Update on the pathophysiology and risk factors for the development of malignant testicular germ cell tumors in complete androgen insensitivity syndrome. Sexual Develop. 2017;11(4):175-81.

Wünsch L, Holterhus PM, Wessel L, Hiort O. Patients with disorders of sex development (DSD) at risk of gonadal tumour development: management based on laparoscopic biopsy and molecular diagnosis. BJU Int. 2012 Dec;110(11c):E958-65.

Lee PA, Nordenström A, Houk CP, Ahmed SF, Auchus R, Baratz A, et al. Global disorders of sex development update since 2006: perceptions, approach and care. Hormone Res Paediatr. 2016;85(3):158-80.